中升控股(00881.HK)與賽力斯簽訂了初步協商協議 明日復牌
格隆匯11月11日丨中升控股(00881.HK)公吿,公司董事會注意到公司股份的股價及交易量近日有所增加以及有關公司潛在合作分銷賽力斯旗下的新能源汽車的網絡新聞。
董事會謹此指出,公司與賽力斯簽訂了初步協商協議,同意就合作分銷其旗下的新能源汽車進行進一步磋商。
董事會確認,除了上述的商業機會以外,其並不知悉有關導致公司股份的成交價格及成交量的任何原因,或任何必須公佈以避免公司證券出現虛假市場的資料,或任何根據香港法例第571章證券及期貨條例第XIVA部須予披露的內幕消息。
公司已向聯交所申請公司股份及債務證券自2024年11月12日上午九時正起恢復買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.